Figure 5
Figure 5. HRG interacts with negatively charged lipids. (A) Analysis of HRGPID (1 μg/mL) binding to an array of different cellular lipids using PIP Strips and SphingoStrips coated with 100 pmoles of the indicated biologically active lipids. (B) Analysis of the ability of HRGPID to bind various phospholipids by ELISA using wells precoated with 50 μg/mL cardiolipin, sulfatide, PtdIns, and PtdIns(4)P, with ethanol coated wells being included as a negative control. (C) Ability of HRG in a HRGP preparation (100 μg/mL) to bind to viable pgsA-745 cells precoated with cardiolipin, sulfatide, PtdIns, and PtdIns(4)P (50 μg/mL, room temperature, 30 minutes). HRG binding was detected by flow cytometry. Representative flow cytometry histograms are shown, with filled black histograms representing Ab-only control and filled gray and open black histograms representing HRG binding to untreated or phospholipid coated cells, respectively.

HRG interacts with negatively charged lipids. (A) Analysis of HRGPID (1 μg/mL) binding to an array of different cellular lipids using PIP Strips and SphingoStrips coated with 100 pmoles of the indicated biologically active lipids. (B) Analysis of the ability of HRGPID to bind various phospholipids by ELISA using wells precoated with 50 μg/mL cardiolipin, sulfatide, PtdIns, and PtdIns(4)P, with ethanol coated wells being included as a negative control. (C) Ability of HRG in a HRGP preparation (100 μg/mL) to bind to viable pgsA-745 cells precoated with cardiolipin, sulfatide, PtdIns, and PtdIns(4)P (50 μg/mL, room temperature, 30 minutes). HRG binding was detected by flow cytometry. Representative flow cytometry histograms are shown, with filled black histograms representing Ab-only control and filled gray and open black histograms representing HRG binding to untreated or phospholipid coated cells, respectively.

Close Modal

or Create an Account

Close Modal
Close Modal